NCT01739023View on ClinicalTrials.gov

Safety of Autologous Human Schwann Cells (ahSC) in Subjects With Subacute SCI

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Spinal Cord InjuryParaplegia
Interventions
BIOLOGICAL

Autologous Human Schwann Cells

Schwann cells harvested from the sural nerve of the participant will be autologously transplanted into the epicenter of the participant's spinal cord injury.

Trial Locations (1)

33136

University of Miami Miller School of Medicine, Miami

All Listed Sponsors
collaborator

The Miami Project to Cure Paralysis

OTHER

lead

W. Dalton Dietrich

OTHER

NCT01739023 - Safety of Autologous Human Schwann Cells (ahSC) in Subjects With Subacute SCI | Biotech Hunter | Biotech Hunter